Skip to main content

Christopher Michael O'Connor

Adjunct Professor in the Department of Medicine
Medicine, Clinical Pharmacology
Duke Box 3356, Durham, NC 27710
7401 Hosp North, Durham, NC 27710

Overview


Dr. O’Connor’s research interests include: acute heart failure; co-morbidities in heart failure; clinical trials; biomarkers; and novel pharmacological and non-pharmacological approaches for the treatment of heart failure.

Current Appointments & Affiliations


Adjunct Professor in the Department of Medicine · 2016 - Present Medicine, Clinical Pharmacology, Medicine

In the News


Published November 19, 2019
Global List of Highly Cited Puts Duke in Top Ten
Published November 27, 2018
Duke Faculty Plentiful On ‘Highly Cited’ List

View All News

Recent Publications


Blood pressure, safety and clinical efficacy of vericiguat in chronic heart failure with reduced ejection fraction: Insights from the VICTOR trial.

Journal Article Eur J Heart Fail · September 29, 2025 AIMS: The efficacy and safety of vericiguat in patients with chronic heart failure with reduced ejection fraction (HFrEF) on contemporary heart failure (HF) therapies and without recent worsening was investigated in the VICTOR trial, yet some subgroups may ... Full text Link to item Cite

Vericiguat for patients with heart failure and reduced ejection fraction across the risk spectrum: an individual participant data analysis of the VICTORIA and VICTOR trials.

Journal Article Lancet · September 27, 2025 BACKGROUND: Following completion of the VICTORIA trial, vericiguat was approved for the treatment of worsening heart failure with reduced ejection fraction (HFrEF) and received a class IIb recommendation in European and North American guidelines. The subse ... Full text Link to item Cite
View All Publications

Recent Grants


Duke-UNC Clinical Hematology and Transfusion Research Career Development Program

ResearchMentor · Awarded by National Institutes of Health · 2006 - 2019

STICHES

Clinical TrialCo Investigator · Awarded by National Institutes of Health · 2011 - 2019

GUIDing Evidence Based Therapy Using Biomarker Intensified Treatment (CCC)

ResearchCo Investigator · Awarded by National Institutes of Health · 2012 - 2017

View All Grants

Education, Training & Certifications


University of Maryland, College Park · 1983 M.D.